BDNF and COMT polymorphisms: Relation to memory phenotypes in young adults with childhood-onset mood disorder

NeuroMolecular Medicine

Volumn 5, Issue 3, 2004, Pages 181-192

  Strauss, J ^a   Barr, C L ^b   George, C J ^c   Ryan, C M ^c   King, N ^a   Shaikh, S ^a   Kovacs, M ^c   Kennedy, J L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Brain derived neurotrophic factor; Childhood; Memory; Mood disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE; METHIONINE; VALINE;

ADOLESCENT; ADULT; ARTICLE; CHILDHOOD DISEASE; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MEMORY; MOOD DISORDER; MULTIVARIATE ANALYSIS OF COVARIANCE; NERVE CELL PLASTICITY; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES IDENTIFICATION; STATISTICAL ANALYSIS; TASK PERFORMANCE;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; BRAIN; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; CHILD; DOPAMINE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTELLIGENCE; MALE; MEMORY; METHIONINE; MOOD DISORDERS; PHENOTYPE; POLYMORPHISM, GENETIC; SEX FACTORS; VALINE;

EID: 12344322392     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/NMM:5:3:181     Document Type: Article

References (77)

1. Alonso M., Vianna M. R., Izquierdo I., and Medina J. H. (2002a) Signaling mechanisms mediating BDNF modulation of memory formation in vivo in the hippocampus. Cell. Mol. Neurobiol. 22, 663-674.
2. Alonso M., Vianna M. R., Depino A. M., et al. (2002b) BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation. Hippocampus 12, 551-560.
3. American Psychiatric Association. (1980) Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., American Psychiatric, Washington, DC.
4. American Psychiatric Association. (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed., American Psychiatric, Washington, DC.
5. Austin M. P., Ross M., Murray C., et al. (1992) Cognitive function in major depression. J. Affect. Disord. 25, 21-29.
6. Barros D. M., Izquierdo L. A., Medina J. H., and Izquierdo I. (2002) Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats. Behav. Pharmacol. 13, 215-220.
7. Bilder R. M., Volavka J., Czobor P, et al. (2002) Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry 52, 701-707.
8. Blumberg S. H. and Izard C. E. (1985) Affective and cognitive characteristics of depression in 10- and 11-year-old children. J. Pers. Soc. Psychol. 49, 194-202.
9. Calev A., Korin Y., Shapira B., et al. (1986) Verbal and non-verbal recall by depressed and euthymic affective patients. Psychol. Med. 16,789-794.
10. Cameron K.A., Yashar S., Wilson C.L., and Fried I.(2001) Human hippocampal neurons predict how well word pairs will be remembered. Neuron 30, 289-298.
11. Cavanagh J. T., Van Beck M., Muir W., and Blackwood D. H. (2002) Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br. J. Psychiatry 180, 320-326.
12. Coello E., Ardila A., and Rosselli M. (1990) Is there a cognitive marker in major depression? Int. J. Neurosci. 50, 137-145.
13. Coppell A. L., Pei Q., and Zetterstrom T. S. (2003) Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44, 903-910.
14. De Mille M. M., Kidd J. R., Ruggeri V., et al. (2002) Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum. Genet. 111, 521-537.
15. Duman R. S. (2002) Synaptic plasticity and mood disorders. Mol. Psychiatry 7, S29-S34.
16. Duman R. S., Malberg J., Nakagawa S., and D'Sa C. (2000) Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 48, 732-739.
17. Egan M. F., Goldberg T. E., Kolachana B. S., et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98, 6917-6922.
18. Egan M. F., Kojima M., Callicott J. H., et al. (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
19. Garzon D., Yu G., and Fahnestock M. (2002) A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J. Neurochem. 82, 1058-1064.
20. Gasparini M., Fabrizio E., Bonifati V, and Meco G. (1997) Cognitive improvement during tolcapone treatment in Parkinson's disease. J. Neural Transm. 104, 887-894.
21. Golan H., Levav T., Mendelsohn A., and Huleihel M. (2004) Involvement of tumor necrosis factor alpha in hippocampal development and function. Cereb. Cortex 14, 97-105.
22. Grunwald T., Beck H., Lehnertz K., et al. (1999) Evidence relating human verbal memory to hippocampal N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA 6, 12,085-12,089.
23. Hall D., Dhilla A., Charalambous A., et al. (2003) Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am. J. Hum. Genet. 73, 370-376.
24. Hariri A. R., Goldberg T. E., Mattay V. S., et al. (2003) Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23, 6690-6694.
25. Harmer C. J., Bhagwagar Z., Cowen P. J., and Goodwin G. M. (2002) Acute administration of citalopram facilitates memory consolidation in healthy volunteers. Psychopharmacology (Berl) 163, 106-110.
26. Ioannidis J. P., Ntzani E. E., Trikalinos T. A., and Contopoulos- Ioannidis D. G. (2001) Replication validity of genetic association studies. Nat. Genet. 29, 306-309.
27. Johnston A. N. and Rose S. P. (2001) Memory consolidation in day-old chicks requires BDNF but not NGF or NT-3; an antisense study. Brain Res. Mol. Brain Res. 88, 26-36.
28. Karege F., Perret G., Bondolfi G., et al. (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109, 143-148.
29. Kaslow N. J., Rehm L. P., and Siegel A. W. (1984) Social-cognitive and cognitive correlates of depression in children. J. Abnorm. Child Psychol. 12, 605-620.
30. Khromova L, Voronina T., Kraineva V. A., Zolotov N., and Mannisto P. T. (1997) Effects of selective catechol-O-methyltransferase inhibitors on single-trial passive avoidance retention in male rats. Behav. Brain Res. 86, 49-57.
31. Kimura D. and Clarke P. G. (2002) Women's advantage on verbal memory is not restricted to concrete words. Psychol. Rep. 91, 1137-1142.
32. Kovacs M., Akiskal H. S., Gatsonis C., and Parrone, P. (1994) Childhood-onset dysthymic disorder. Clinical features and prospective naturalistic outcome. Arch. Gen. Psychiatry 51, 365-374.
33. Kovacs M., Feinberg T. L., Crouse-Novak M. A., et al. (1984) Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Arch. Gen. Psychiatry 41, 229-237.
34. Kunugi H., Ueki A., Otsuka M., et al. (2001) A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol. Psychiatry 6, 83-86.
35. Kunugi H., Vallada H. P., Sham P. C., et al. (1997) Catechol-O- methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr. Genet. 7, 97-101.
36. Lahiri D. K. and Nurnberger J. I., Jr. (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucleic Acids Res. 19, 5444.
37. Levine T. R. and Hullett C. R. (2002) Eta squared, partial eta squared, and misreporting of effect size in communication research. Hum. Comm. Res. 28, 612-625.
38. Levkovitz Y., Caftori R., Avital A., and Richter-Levin G. (2002) The SSRI drug fluoxetine, but not the noradrenergic tricyclic drug desipramine, improves memory performance during acute major depression. Brain Res. Bull. 58, 345-350.
39. Liljequist R., Haapalinna A., Ahlander M., et al. (1997) Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav. Brain Res. 82, 195-202.
40. Liu D., Diorio J., Day J. C., et al. (2000) Maternal care, hippocampal synaptogenesis and cognitive development in rats. Nat. Neurosci. 3, 799-806.
41. Lu B. and Gottschalk W. (2000) Modulation of hippocampal synaptic transmission and plasticity by neurotrophins. Prog. Brain Res. 128, 231-241.
42. MacQueen G.M., Campbell S., and McEwen B. S.(2003) Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl. Acad. Sci. USA 100, 1387-1392.
43. Marcos T., Salamero M., Gutierrez F., et al. (1994) Cognitive dysfunctions in recovered melancholic patients. J. Affect. Disord. 32, 133-137.
44. Miller L. A., Lai R., and Munoz D. G. (1998) Contributions of the entorhinal cortex, amygdala and hippocampus to human memory. Neuropsychologia 36, 1247-1256.
45. Molteni R., Wu A., Vaynman S., Ying Z., Barnard R. J., and Gomez-Pinilla F. (2004) Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brain-derived neurotrophic factor. Neuroscience 123, 429-40.
46. Mu J. S., Li W. P., Yao Z. B., and Zhou X. F. (1999) Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res. 835, 259-265.
47. Nakata K., Ujike H., Sakai A., et al. (2003) Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci. Lett. 337, 17-20.
48. Neves-Pereira M., Mundo E., Muglia P., et al. (2002) The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71, 651-655.
49. Nibuya M., Morinobu S., and Duman R. S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539-7547.
50. Osterrieth P. A. (1944) Le test de copie d'une figure complex: contribution a l'etude de la perception et de la memoire. Arch. Psychol. 30, 286-356.
51. Posener J. A., Wang L., Price J. L., et al. (2003) High-dimensional mapping of the hippocampus in depression. Am. J. Psychiatry 160, 83-89.
52. Proschel M., Saunders A., Roses A. D., and Muller C. R. (1992) Dinucleotide repeat polymorphisms at the human gene for brain-derived neurotrophic factor (BDNF). Hum. Mol. Genet. 1, 353.
53. Rey A. (1941) L'examen psychologique dans les cas d'encephalopathie tramatique. Arch. Psychol. 28, 286-340.
54. Riemenschneider M., Schwarz S., Wagenpfeil S., et al. (2002) A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol. Psychiatry 7, 782-785.
55. Russo-Neustadt A., Ha T., Ramirez R., and Kesslak J. P. (2001) Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav. Brain Res. 120, 87-95.
56. Ryan C., Vega A., Longstreet C., and Drash A. (1984) Neuropsychological changes in adolescents with insulin-dependent diabetes. J. Consult. Clin. Psychol. 52, 335-342.
57. SAS Institute Inc. (1999) SAS OnlineDoc®, Version 8., SAS Institute Inc., Cary, NC.
58. Sattler J. M. (1988) Assessment of Children, 3rd ed., J. M. Sattler, San Diego, CA.
59. Seidman L. J., Kremen W. S., Koren D., Faraone S. V., Goldstein J. M., and Tsuang M. T. (2002) A comparative profile analysis of neuropsychological functioning in patients with schizophrenia and bipolar psychoses. Schizophr. Res. 53, 31-44.
60. Sen S., Nesse R. M., Stoltenberg S. F., et al. (2003) A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28, 397-401.
61. Sheline Y. I., Gado M. H., and Kraemer H. C. (2003) Untreated depression and hippocampal volume loss. Am. J. Psychiatry 160, 1516-1518.
62. Sheline Y. I., Wany P., Gado M. H., Csernansky J. G., and Vannier M. W. (1996) Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 93, 2897-2902.
63. Sherril J. T. and Kovacs M. (2000) Interview schedule for children and adolescents (ISCA). J. Am. Acad. Child Adolesc. Psychiatry 39, 67-75.
64. Sklar P., Gabriel S. B., McInnis M. G., et al. (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol. Psychiatry 7, 579-593.
65. Spreen O. and Strauss E. (1998). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 2nd ed., Oxford University Press, New York.
66. Strauss J., Barr C. L., George C. J., et al. (2004) Association study of brain-derived neurotrophic factor in adults with a history of childhood-onset mood disorder. Am. J. Med. Genet. (Neuropsychiatric Genetics), in press.
67. Taubenfeld S. M., Milekic M. H., Monti B., and Alberini C. M. (2001) The consolidation of new but not reactivated memory requires hippocampal C/EBP-beta. Nat. Neurosci. 4, 813-818.
68. Tokuyama W., Okuno H., Hashimoto T., et al. (2000) BDNF upregulation during declarative memory formation in monkey inferior temporal cortex. Nat. Neurosci. 3, 1134-1142.
69. Tyler W. J., Alonso M., Bramham C. R., et al. (2002) From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn. Mem. 9, 224-237.
70. Vicario-Abejon C., Owens D., McKay R., and Segal M. (2002) Role of neurotrophins in central synapse formation and stabilization. Nat. Rev. Neurosci. 3, 965-974.
71. Waldman I. D., Robinson B. F., and Rowe D. C. (1999) A logistic regression based extension of the TDT for continuous and categorical traits. Ann. Hum. Genet. 63, 329-340.
72. Wechsler D. (1945) A standardized memory scale for clinical use. J. Psychol. 19, 87-95.
73. Wechsler D. (1974) Wechsler Intelligence Scale for Children, Revised, Psychological Corporation, New York.
74. Wechsler D. (1981) Wechsler Adult Intelligence Scale, Revised, Psychological Corporation, New York.
75. Weeber E. J. and Sweatt D. J. (2002) Molecular neurobiology of human cognition. Neuron 33, 845-848.
76. Yau J. L., Noble J., Hibberd C., et al. (2002) Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J. Neurosci. 22, 1436-1442.
77. Zakzanis K. K., Leach L., and Kaplan E. (1998) On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol. Behav. Neurol. 11, 111-119.